Soluble Fas/FasLare elevated in the serum and cerebrospinal fluid of patients with neurocysticercosis.

about

Soluble Fas/FasLare elevated in the serum and cerebrospinal fluid of patients with neurocysticercosis.

Item

http://www.wikidata.org/entity/Q47891474

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Soluble Fas/FasLare elevated i ...... ients with neurocysticercosis.

@en

Soluble Fas/FasLare elevated i ...... ients with neurocysticercosis.

@nl

type

Item

label

Soluble Fas/FasLare elevated i ...... ients with neurocysticercosis.

@en

Soluble Fas/FasLare elevated i ...... ients with neurocysticercosis.

@nl

prefLabel

Soluble Fas/FasLare elevated i ...... ients with neurocysticercosis.

@en

Soluble Fas/FasLare elevated i ...... ients with neurocysticercosis.

@nl

P1476

Soluble Fas/FasLare elevated i ...... ients with neurocysticercosis.

@en

P2093

Jiankui Zhu

http://www.w3.org/2001/XMLSchema#string

Junchao Gu

http://www.w3.org/2001/XMLSchema#string

Xiaohua Chen

http://www.w3.org/2001/XMLSchema#string

Xuan Yu

http://www.w3.org/2001/XMLSchema#string

Yipeng Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses

Proposed diagnostic criteria for neurocysticercosis

Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity.

Apoptosis in the nervous system.

Review: apoptotic mechanisms in bacterial infections of the central nervous system.

Clinical aspects of neurocysticercosis.

Death receptor Fas (CD95) signaling in the central nervous system: tuning neuroplasticity?

Apoptosis induced by parasitic diseases

Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus.

Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.

P2888

s00436-017-5613-9

P304

3027-3036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00436-017-5613-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28965226

http://www.w3.org/2001/XMLSchema#string

P921

neurocysticercosis

cerebrospinal fluid